Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor (APATC)

April 30, 2026 updated by: Center Eugene Marquis

The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.

The main question it aims to answer is:

What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?

Additional questions include:

  • What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program?
  • What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)?
  • What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?

Participants will:

  • Undergo a 3-month supervised APA program (with possible continuation beyond this period).
  • Use connected watches to monitor physical activity (if they accept the general conditions of use).
  • Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months.
  • Be followed for a total of 4 months after inclusion.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rennes, France, 35000
        • Centre Eugene Marquis
        • Contact:
        • Principal Investigator:
          • Elodie VAULEON, DR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men or women ≥ 18 years old,
  • Receiving medical oncology treatment at the CLCC Eugène Marquis,
  • Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment,
  • Possible motor, sensory, attention, concentration, or memory deficits,
  • Patients who accept the general terms of use for connected watches
  • Patients affiliated with or covered by the French social security system,
  • Patients who have received information and signed informed consent (or their legal representative),

Exclusion Criteria:

  • WHO score ≥ 3
  • Comprehension disorders that prevent participation in adapted physical activity
  • Pregnant or breastfeeding women
  • Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer),
  • Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure.

Patients unable to comply with the study schedule for social, medical, or psychological reasons.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PA with Strength Sheets + Walking Recommendation
Patients receive 2 strength exercise sheets to perform weekly at home + a recommendation to walk regularly (30 min/day). No supervised sessions. Activity is self-monitored via connected watch.
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.
Experimental: APA with Strength Sheet + Group Videoconference Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of group training via videoconference per week. The videoconference session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.
Experimental: APA with Strength Sheet + Individual Home Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of individualized and personalized training at home per week. The home session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effective adherence rate to the Adapted Physical Activity (APA) program
Time Frame: Baseline to 4 months
The primary outcome is the proportion of eligible patients who participate in at least one APA session out of the total number of eligible patients solicited for inclusion. This metric Evaluates the feasibility of APA implementation in brain tumor patients.
Baseline to 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
APA program observance rate
Time Frame: Baseline to 4 months
Evaluated through the number of sessions completed, the number of sessions reaching the recommended intensity level, and the duration of sessions performed during the 3-month supervised period and the 1-month autonomous period.
Baseline to 4 months
Retention rate during the 3-month supervised APA period
Time Frame: Baseline to 3 months
Proportion of patients who complete the entire 3-month supervised APA program, reflecting their commitment and ability to sustain participation.
Baseline to 3 months
Retention Rate After Supervised APA Period
Time Frame: 4 months
Proportion of patients who continue APA beyond the initial 3-month supervised period, assessed at 4 months.
4 months
Reasons for early discontinuation of APA
Time Frame: Baseline to 4 months
Documentation of specific reasons (e.g., fatigue, disease progression, lack of motivation) for patients who discontinue APA prematurely.
Baseline to 4 months
uality of life assessment using QLQ-BN20 questionnaire (EORTC Quality of Life Questionnaire - Brain Neoplasm Module 20)
Time Frame: Baseline, 3 months, and 4 months
Evaluation of brain tumor-specific quality of life using the EORTC QLQ-BN20 questionnaire, which assesses symptoms and functional domains relevant to brain tumor patients.
Baseline, 3 months, and 4 months
Anxiety and depression assessment using HADS (Hospital Anxiety and Depression Scale) questionnaire
Time Frame: Baseline, 3 months, and 4 months
Evaluation of anxiety and depression levels using the Hospital Anxiety and Depression Scale (HADS), a validated tool for assessing psychological distress.
Baseline, 3 months, and 4 months
Fatigue assessment using MFI-20 (Multidimensional Fatigue Inventory-20) questionnaire
Time Frame: Baseline, 3 months, and 4 months
Evaluation of multidimensional fatigue (general, physical, mental, reduced motivation, and reduced activity) using the Multidimensional Fatigue Inventory (MFI-20).
Baseline, 3 months, and 4 months
Physical activity level assessment using IPAQ (International Physical Activity Questionnaire) questionnaire
Time Frame: Baseline, 3 months, and 4 months
Evaluation of physical activity intensity and frequency using the International Physical Activity Questionnaire (IPAQ), which classifies participants into low, moderate, or high activity levels.
Baseline, 3 months, and 4 months
Motivation for physical activity assessment using BREQ-2 -Behavioral Regulation in Exercise Questionnaire - Version 2) questionnaire
Time Frame: Baseline, 3 months, and 4 months
Evaluation of motivation types (intrinsic, identified, introjected, external) using the Behavioral Regulation in Exercise Questionnaire (BREQ-2).
Baseline, 3 months, and 4 months
Perceived enjoyment of physical activity assessment using PACES (Physical Activity Enjoyment Scale) questionnaire
Time Frame: Baseline, 3 months, and 4 months
Evaluation of enjoyment and satisfaction related to physical activity using the PACES questionnaire.
Baseline, 3 months, and 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Elodie VAULEON, Dr, Centre de lutte contre le cancer Eugène Marquis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

April 30, 2026

First Submitted That Met QC Criteria

April 30, 2026

First Posted (Actual)

May 6, 2026

Study Record Updates

Last Update Posted (Actual)

May 6, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Tumor Adult

Clinical Trials on adapted physical activity

Subscribe